Core Laboratories N.V. CLB
$ 21.39
5.27%
Quarterly report 2023-Q1
added 04-27-2023
Core Laboratories N.V. Balance Sheet 2011-2024 | CLB
Annual Balance Sheet Core Laboratories N.V.
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
185 M | 313 M | 371 M | 277 M | 213 M | 202 M | 408 M | 333 M | 242 M | 215 M | 196 M |
Long Term Debt |
190 M | 259 M | 305 M | 290 M | 227 M | 216 M | 431 M | 356 M | 267 M | 234 M | 223 M |
Long Term Debt Current |
12.3 M | 11.4 M | 11.8 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 403 M | 481 M | 385 M | 331 M | 314 M | 528 M | 450 M | 356 M | 308 M | 286 M |
Total Current Liabilities |
90.8 M | 89.8 M | 112 M | 103 M | 105 M | 104 M | 121 M | 132 M | 136 M | 141 M | 137 M |
Total Liabilities |
- | 493 M | 593 M | 488 M | 436 M | 418 M | 649 M | 582 M | 492 M | 449 M | 423 M |
Deferred Revenue |
1.3 M | 5.46 M | 13.4 M | 17.3 M | 17.1 M | 15.7 M | 14.1 M | 11 M | 10.9 M | 13.9 M | 19.2 M |
Retained Earnings |
68.3 M | 50.5 M | 161 M | 156 M | 174 M | 188 M | 219 M | 416 M | 416 M | 361 M | 284 M |
Total Assets |
581 M | 569 M | 775 M | 649 M | 585 M | 573 M | 625 M | 676 M | 661 M | 637 M | 605 M |
Cash and Cash Equivalents |
17.7 M | 13.8 M | 11.1 M | 13.1 M | 14.4 M | 14.8 M | 22.5 M | 23.4 M | 25.1 M | 19.2 M | 29.3 M |
Book Value |
581 M | 75.6 M | 182 M | 161 M | 149 M | 155 M | -23.7 M | 94 M | 169 M | 188 M | 182 M |
Total Shareholders Equity |
156 M | 71.5 M | 178 M | 157 M | 145 M | 151 M | -29.1 M | 87.6 M | 163 M | 182 M | 178 M |
All numbers in USD currency
Quarterly Balance Sheet Core Laboratories N.V.
2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
180 M | 172 M | - | - | 190 M | 189 M | 188 M | 208 M | 208 M | 259 M | 259 M | 259 M | 259 M | 305 M | 305 M | 305 M | 305 M | 290 M | 290 M | 290 M | 290 M | 227 M | 227 M | 227 M | 227 M | 216 M | 216 M | 216 M | 216 M | 431 M | 431 M | 431 M | 431 M | 354 M | 356 M | 356 M | 356 M | 267 M | 267 M | 267 M | 267 M | 234 M | 234 M | 234 M | 234 M | 223 M | 223 M | 223 M | 223 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
794 K | 907 K | - | - | 2.06 M | 1.3 M | 1.32 M | 1.17 M | 1.07 M | 953 K | 953 K | 953 K | 953 K | 4.47 M | 4.47 M | 4.47 M | 4.47 M | 5.96 M | 15.3 M | 12.6 M | 11.8 M | 12.6 M | 14.3 M | 12.6 M | 12.6 M | 15.7 M | 15.7 M | 15.7 M | 15.7 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 11 M | 11 M | 11 M | 11 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M |
Retained Earnings |
87.9 M | 85.9 M | - | - | 66 M | 68.3 M | 66.1 M | 65.7 M | 58.1 M | 50.5 M | 50.5 M | 50.5 M | 50.5 M | 161 M | 161 M | 161 M | 161 M | 156 M | 156 M | 156 M | 156 M | 174 M | 174 M | 174 M | 174 M | 188 M | 188 M | 188 M | 188 M | 219 M | 219 M | 219 M | 219 M | 416 M | 416 M | 416 M | 416 M | 416 M | 416 M | 416 M | 416 M | 361 M | 361 M | 361 M | 361 M | 284 M | 284 M | 284 M | 284 M |
Total Assets |
594 M | 578 M | - | - | 585 M | 581 M | 586 M | 598 M | 584 M | 569 M | 569 M | 569 M | 569 M | 775 M | 775 M | 775 M | 775 M | 649 M | 649 M | 649 M | 649 M | 585 M | 585 M | 585 M | 585 M | 573 M | 573 M | 573 M | 573 M | 625 M | 625 M | 625 M | 625 M | 673 M | 676 M | 676 M | 676 M | 659 M | 661 M | 661 M | 661 M | 637 M | 637 M | 637 M | 637 M | 611 M | 611 M | 611 M | 605 M |
Cash and Cash Equivalents |
16.3 M | 15.4 M | - | - | 22 M | 17.7 M | 19 M | 33.6 M | 27.8 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 14.8 M | 14.8 M | 14.8 M | 14.8 M | 22.5 M | 22.5 M | 22.5 M | 22.5 M | 23.4 M | 23.4 M | 23.4 M | 23.4 M | 25.1 M | 25.1 M | 25.1 M | 25.1 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 29.3 M | 29.3 M | 29.3 M | 29.3 M |
Book Value |
594 M | 578 M | - | - | 585 M | 581 M | 586 M | 598 M | 584 M | 569 M | 569 M | 569 M | 569 M | 775 M | 775 M | 775 M | 775 M | 649 M | 649 M | 649 M | 649 M | 585 M | 585 M | 585 M | 585 M | 573 M | 573 M | 573 M | 573 M | 625 M | 625 M | 625 M | 625 M | 673 M | 676 M | 676 M | 676 M | 659 M | 661 M | 661 M | 661 M | 637 M | 637 M | 637 M | 637 M | 611 M | 611 M | 611 M | 605 M |
Total Shareholders Equity |
195 M | 184 M | - | - | 166 M | 156 M | 157 M | 150 M | 142 M | 71.5 M | 71.5 M | 71.5 M | 71.5 M | 178 M | 178 M | 178 M | 178 M | 157 M | 157 M | 157 M | 157 M | 145 M | 145 M | 145 M | 145 M | 151 M | 151 M | 151 M | 151 M | -29.1 M | -29.1 M | -29.1 M | -29.1 M | 87.6 M | 87.6 M | 87.6 M | 87.6 M | 163 M | 163 M | 163 M | 163 M | 182 M | 182 M | 182 M | 182 M | 178 M | 178 M | 178 M | 178 M |
All numbers in USD currency